4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-015283
President & Co-CEO gave up 350,978 shares (to pay taxes)
- President & Co-CEO acquired 886,468 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Chirag K. President & Co-CEO | 2026-03-03 | Option exercise | +59,931 | 917,911 | D | ||
| Patel Chirag K. President & Co-CEO | 2026-03-03 | Shares withheld for taxes | −15,616 | $13.31 | $207,849 | 902,295 | D |
| Patel Chirag K. President & Co-CEO | 2026-03-03 | Option exercise | +733,944 | 1,636,239 | D | ||
| Patel Chirag K. President & Co-CEO | 2026-03-03 | Shares withheld for taxes | −297,537 | $13.31 | $3,960,217 | 1,338,702 | D |
| Patel Chirag K. President & Co-CEO | 2026-03-04 | Option exercise | +92,593 | 1,431,295 | D | ||
| Patel Chirag K. President & Co-CEO | 2026-03-04 | Shares withheld for taxes | −37,825 | $13.30 | $503,073 | 1,393,470 | D |
| Derivatives | |||||||
| Patel Chirag K. President & Co-CEO | 2026-03-03 | Option exercise · Restricted Stock Units | −59,931 | 179,795 | D | ||
| Patel Chirag K. President & Co-CEO | 2026-03-03 | Option exercise · Performance-Based Restricted Stock Units | −733,944 | 0 | D | ||
| Patel Chirag K. President & Co-CEO | 2026-03-04 | Option exercise · Restricted Stock Units | −92,593 | 185,185 | D | ||
Loading xslF345X05/wk-form4_1772747515.xml…